论文部分内容阅读
目的:研究组氨酸对脑血栓形成的影响及可能机制.方法:采用光化学诱导“脑—心卒中”模型并给组氨酸(iv5mg·kg-1)治疗.结果:脑血栓形成后4和24h全血血小板聚集的峰值为(51±05)Ω和(43±05)Ω.心肌线粒体体积(V)、体密度(Vv)、面密度(Nm)及外膜表面(Sv1)增加(82±55,059±016,011±003和22±005,P<001),但数密度(Nv)、内膜比表面(δ2)和嵴膜比表面(δ3)减少(007±002,28±08和24±07,P<001),心肌病理学改变有别于缺血性坏死和缺血再灌所致的心脏损伤.组氨酸治疗后,全血血小板聚集降为(29±11)Ω(P<001),与内膜有关的体视学参数可逆改变.结论:组氨酸可抑制全血血小板聚集,并减轻由于脑缺血所致的心肌线粒体损伤.
Objective: To investigate the effect of histidine on cerebral thrombosis and its possible mechanism. Methods: The model of “brain-stroke” was induced by photochemistry and treated with histidine (iv5mg · kg-1). Results: The peak values of platelet aggregation at 4 and 24 h after thrombosis were (51 ± 05) Ω and (43 ± 05) Ω. Myocardial mitochondrial volume (V), body density (Vv), surface density (Nm) and outer membrane surface (Sv1) increased (8 2 5 5,0 59 ± 0 16,0 11 ± 0 03 And 22 ± 005, P <001), but the number density (Nv), specific surface area (δ2) and specific surface area of crest membrane (δ3) decreased (007 ± 002, 2 8 ± 08 and 24 ± 07, P <001). The pathological changes of myocardium were different from those of ischemic necrosis and ischemia-reperfusion. After treatment with histidine, whole blood platelet aggregation was reduced to (29 ± 11) Ω (P <001), and the endomicroscopic parameters of stereology were reversibly changed. Conclusion: Histidine can inhibit whole blood platelet aggregation and mitigate myocardial mitochondrial damage due to cerebral ischemia.